Lab Shresta
Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation
LJI scientists win ‘Prebys Research Heroes’ funding
Prebys Foundation celebrates ground-breaking female researchers
Common cold or COVID-19? Some T cells are ready to combat both
New LJI research demonstrates the importance of harnessing "cross-reactive" T cells to combat SARS-CoV-2
LJI-led team wins top Nucleate honors for virus vaccine development proposal
San Diego scientists work with business experts to advance dengue and Zika virus vaccine strategy
LJI Instructor Annie Elong Ngono, Ph.D., wins GVN support to advance infectious disease research
Elong Ngono, Ph.D., accepted to Global Virus Network Rising Star Mentorship Program
How human cells become Zika virus factories
LJI scientists uncover major clue toward developing a pan-flavivirus therapy
The life of a scientist studying Zika and dengue
Inside the work of immunologist Julia Timis
LJI and Charles River Laboratories to collaborate on COVID-19 research
New agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2
Fernanda Ana-Sosa-Batiz wins AAI fellowship
"This fellowship opens up a lot of future opportunities.”
LJI and Synbal, Inc. partner to develop better COVID-19 models
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
Building true partnerships with overseas labs
As she advances global health, LJI Professor Sujan Shresta takes on three new research projects to support equity for scientists in South and Southeast Asia
Fighting Zika? Call in the T cells
Stopping emerging viruses could depend on getting T cells and antibodies to work together
Fighting mosquito-borne viruses requires a precise balance of immune cells
Future vaccines will need to harness the power of T cells in preventing Zika fever and Japanese encephalitis
